Drug recall · April 13, 2022
SYMJEPI recall
Why: Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.
- Lots / codes
Lot # 21101Y, Exp. 11/30/2022
- Quantity
- 2,500 cartons
- Company
- Adamis Pharmaceuticals Corporation, San Diego, CA
- Distribution
- Nationwide in the U.S.A.
- Initiated
- March 21, 2022 · Voluntary: Firm initiated
- Classified
- April 8, 2022
- Reported
- April 13, 2022
- Ended
- February 8, 2023
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.